<?xml version='1.0' encoding='utf-8'?>
<document id="27306862"><sentence text="Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome."><entity charOffset="55-64" id="DDI-PubMed.27306862.s1.e0" text="berberine" /></sentence><sentence text="Polycystic ovary syndrome (PCOS) is a common multifactorial endocrine disorder among women of childbearing age" /><sentence text=" PCOS has various and heterogeneous clinical features apart from its indefinite pathogenesis and mechanism" /><sentence text=" Clinical drugs for PCOS are multifarious because it only treats separate symptoms" /><sentence text=" Berberine is an isoquinoline plant alkaloid with numerous biological activities, and it was testified to improve some diseases related to PCOS in animal models and in humans"><entity charOffset="1-10" id="DDI-PubMed.27306862.s5.e0" text="Berberine" /><entity charOffset="17-29" id="DDI-PubMed.27306862.s5.e1" text="isoquinoline" /><entity charOffset="36-44" id="DDI-PubMed.27306862.s5.e2" text="alkaloid" /><pair ddi="false" e1="DDI-PubMed.27306862.s5.e0" e2="DDI-PubMed.27306862.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27306862.s5.e0" e2="DDI-PubMed.27306862.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27306862.s5.e0" e2="DDI-PubMed.27306862.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27306862.s5.e1" e2="DDI-PubMed.27306862.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27306862.s5.e1" e2="DDI-PubMed.27306862.s5.e2" /></sentence><sentence text=" Systems pharmacology was utilized to predict the potential targets of berberine related to PCOS and the potential drug-drug interaction base on the disease network"><entity charOffset="71-80" id="DDI-PubMed.27306862.s6.e0" text="berberine" /></sentence><sentence text=" In conclusion, berberine is a promising polypharmacological drug for treating PCOS, and for enhancing the efficacy of clinical drugs"><entity charOffset="16-25" id="DDI-PubMed.27306862.s7.e0" text="berberine" /></sentence><sentence text="" /></document>